| 12:33:02 | 12:33:02 | 10 Sept 2026 | | Holding(s) in Company | RNS |
| 07/09/26 | 12:15:28 | 7 Sept 2026 | | Result of General Meeting | RNS |
| 20/08/26 | 16:13:28 | 20 Aug 2026 | | Proposed Placing & Subscription to raise £1.05m | RNS |
| 24/06/26 | 16:34:55 | 24 Jun 2026 | | Holding(s) in Company | RNS |
| 26/05/26 | 14:40:11 | 26 May 2026 | | Holding(s) in Company | RNS |
| 15/05/26 | 12:43:38 | 15 May 2026 | | Holding(s) in Company | RNS |
| 15/05/26 | 07:00:04 | 15 May 2026 | | Holding(s) in Company | RNS |
| 14/05/26 | 07:00:03 | 14 May 2026 | | Positive Ox-1 tox data in addiction programme | RNS |
| 21/04/26 | 07:00:08 | 21 Apr 2026 | | Investor Webinar | RNS |
| 20/04/26 | 07:00:04 | 20 Apr 2026 | | Successful GMP Manufacture Advances Ox-1 to Clinic | RNS |
| 16/04/26 | 07:00:01 | 16 Apr 2026 | | New Manufacturing Process Patent for Ox-1 | RNS |
| 14/04/26 | 07:00:02 | 14 Apr 2026 | | Non-Binding Proposal to Acquire TheraCryf’s Assets | RNS |
| 23/03/26 | 07:00:03 | 23 Mar 2026 | | Ox-1 Programme Advances to Final Toxicology Study | RNS |
| 26/01/26 | 07:00:02 | 26 Jan 2026 | | Ox-1 Addiction Programme Update | RNS |
| 05/01/26 | 07:00:07 | 5 Jan 2026 | | Key Ox-1 milestone & notice of investor webinar | RNS |
| 18/12/25 | 07:00:08 | 18 Dec 2025 | | Potential of Preclinical Program in Mental Fatigue | RNS |
| 03/12/25 | 07:00:08 | 3 Dec 2025 | | Half-year Financial Report | RNS |
| 26/11/25 | 07:00:14 | 26 Nov 2025 | | Marking Addiction Awareness Week | RNS |
| 24/11/25 | 07:00:11 | 24 Nov 2025 | | Notice of Results | RNS |
| 03/11/25 | 07:00:12 | 3 Nov 2025 | | Ox-1 Programme Achieves Manufacturing Milestone | RNS |
| 16/10/25 | 16:45:00 | 16 Oct 2025 | | Holding(s) in Company | RNS |
| 16/10/25 | 16:45:00 | 16 Oct 2025 | | Director/PDMR Shareholding | RNS |
| 10/10/25 | 07:00:10 | 10 Oct 2025 | | World Mental Health Day & Q4 Conference Schedule | RNS |
| 26/09/25 | 15:45:09 | 26 Sept 2025 | | Holding(s) in Company | RNS |
| 08/09/25 | 11:38:52 | 8 Sept 2025 | | Holding(s) in Company | RNS |
| 04/09/25 | 07:00:16 | 4 Sept 2025 | | Ox-1 Patent Grant & Development Programme Update | RNS |
| 04/08/25 | 15:27:01 | 4 Aug 2025 | | Holding(s) in Company | RNS |
| 17/07/25 | 07:00:05 | 17 Jul 2025 | | Manufacturing Scale Up of Lead Ox-1 Programme | RNS |
| 09/07/25 | 15:07:47 | 9 Jul 2025 | | Result of AGM | RNS |
| 09/07/25 | 07:00:08 | 9 Jul 2025 | | AGM Statement | RNS |
| 16/06/25 | 16:10:39 | 16 Jun 2025 | | Notice of AGM | RNS |
| 13/06/25 | 07:00:02 | 13 Jun 2025 | | Change of Adviser | RNS |
| 10/06/25 | 12:32:47 | 10 Jun 2025 | | Ox-1 Investor Presentation | RNS |
| 03/06/25 | 07:00:10 | 3 Jun 2025 | | Final results for year to 31 March 2025 | RNS |
| 23/05/25 | 07:14:41 | 23 May 2025 | | Notice of Results and Ox-1 presentation | RNS |
| 22/05/25 | 12:43:23 | 22 May 2025 | | Holding(s) in Company | RNS |
| 22/05/25 | 12:22:22 | 22 May 2025 | | Director/PDMR Shareholding | RNS |
| 16/05/25 | 13:00:27 | 16 May 2025 | | Holding(s) in Company | RNS |
| 12/05/25 | 07:00:06 | 12 May 2025 | | Master Service Agreement signed for Ox-1 programme | RNS |
| 01/05/25 | 07:00:11 | 1 May 2025 | | Board Appointment, Grant of Options, PDMR Dealing | RNS |
| 26/03/25 | 07:00:13 | 26 Mar 2025 | | Investor webinar | RNS |
| 21/03/25 | 15:55:11 | 21 Mar 2025 | | Holding(s) in Company | RNS |
| 20/03/25 | 15:33:42 | 20 Mar 2025 | | Holding(s) in Company | RNS |
| 20/03/25 | 11:01:16 | 20 Mar 2025 | | Holding(s) in Company | RNS |
| 19/03/25 | 12:10:15 | 19 Mar 2025 | | Holding(s) in Company | RNS |
| 17/03/25 | 14:17:52 | 17 Mar 2025 | | Holding(s) in Company | RNS |
| 17/03/25 | 07:00:09 | 17 Mar 2025 | | Holding(s) in Company | RNS |
| 17/03/25 | 07:00:09 | 17 Mar 2025 | | Holding(s) in Company | RNS |
| 17/03/25 | 07:00:09 | 17 Mar 2025 | | Holding(s) in Company | RNS |
| 13/03/25 | 07:00:14 | 13 Mar 2025 | | Holding(s) in Company | RNS |
